BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE

被引：0
|
作者：
TAYLOR, WB [1 ]
BATEMAN, DN [1 ]
机构：
[1] UNIV NEWCASTLE UPON TYNE,WOLFSON UNIT CLIN PHARMACOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P296 / P296
页数：1
相关论文
共 50 条
  • [1] ORAL BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE
    TAYLOR, WB
    BATEMAN, DN
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) : 41 - 44
  • [2] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE
    ROILA, F
    TONATO, M
    DELFAVERO, A
    BALLATORI, E
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 440 - 441
  • [3] EXTRAPYRAMIDAL REACTIONS WITH HIGH-DOSE METOCLOPRAMIDE
    ELL, C
    KONIG, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (01) : 38 - 38
  • [4] EXTRAPYRAMIDAL REACTIONS WITH HIGH-DOSE METOCLOPRAMIDE
    KRIS, MG
    TYSON, LB
    GRALLA, RJ
    CLARK, RA
    ALLEN, JC
    REILLY, LK
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (07): : 433 - 434
  • [5] A PHARMACOKINETIC STUDY OF HIGH-DOSE METOCLOPRAMIDE SUPPOSITORIES
    HARDY, F
    WARRINGTON, PS
    MACPHERSON, JS
    HUDSON, SA
    JEFFERSON, GC
    SMYTH, JF
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1990, 15 (01) : 21 - 24
  • [6] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE - REPLY
    HRUSHESKY, WJM
    VONROEMELING, R
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 441 - 441
  • [7] HIGH-DOSE METOCLOPRAMIDE IN CISPLATIN TREATED PATIENTS
    FRUSTACI, S
    TIRELLI, U
    TUMOLO, S
    VERONESI, A
    GALLIGIONI, E
    TROVO, M
    GRIGOLETTO, E
    CHEMIOTERAPIA, 1983, 2 (02): : 75 - 77
  • [8] LACK OF ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE
    ROEMELING, RV
    CHRISTIANSEN, NP
    HRUSHESKY, WJM
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) : 1273 - 1276
  • [9] HIGH-DOSE METOCLOPRAMIDE - PRELIMINARY PHARMACOKINETIC STUDIES
    TAYLOR, WB
    BATEMAN, DN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (03) : 341 - 342
  • [10] HIGH-DOSE DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE VERSUS HIGH-DOSE DEXAMETHASONE AND SULPIRIDE IN THE MANAGEMENT OF CISPLATIN-INDUCED EMESIS
    ROSENBLATT, E
    LEV, LM
    ROBINSON, E
    ONCOLOGY, 1988, 45 (04) : 297 - 299
12345